Comparing tumour heterogeneity in primary tumour, circulating tumour cells and metastases
- Conditions
- SCLC niet kleincellig longcarcinoom, longkankerlungcancer, tumour heterogeneity, tumor heterogeniteit, CTC, circulating tumour cell, circulerende tumor cel
- Registration Number
- NL-OMON29203
- Lead Sponsor
- niversity Medical Centre Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Patients with a histologically/cytologically proven pulmonary malignancy.
2.Patients have to have a non-curable disease state, without curative treatment options
Exclusion Criteria
1.No growth factor medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - heterogeneity and mutational load measurements in all compartments. These can subsequently be compared to one another.
- Secondary Outcome Measures
Name Time Method